Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life.

Iacono D, Markesbery WR, Gross M, Pletnikova O, Rudow G, Zandi P, Troncoso JC.

Neurology. 2009 Sep 1;73(9):665-73. doi: 10.1212/WNL.0b013e3181b01077. Epub 2009 Jul 8.

2.

Neuronal hypertrophy in asymptomatic Alzheimer disease.

Iacono D, O'Brien R, Resnick SM, Zonderman AB, Pletnikova O, Rudow G, An Y, West MJ, Crain B, Troncoso JC.

J Neuropathol Exp Neurol. 2008 Jun;67(6):578-89. doi: 10.1097/NEN.0b013e3181772794.

3.

Compensating for Alzheimer lesions: evidence that size counts.

Lippa CF.

Neurology. 2009 Sep 1;73(9):656-7. doi: 10.1212/WNL.0b013e3181b61b4c. Epub 2009 Jul 29. No abstract available.

PMID:
19641170
4.

APOε2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun Study.

Iacono D, Zandi P, Gross M, Markesbery WR, Pletnikova O, Rudow G, Troncoso JC.

Oncotarget. 2015 Jun 10;6(16):14082-91.

5.

Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes.

Iacono D, Resnick SM, O'Brien R, Zonderman AB, An Y, Pletnikova O, Rudow G, Crain B, Troncoso JC.

J Neuropathol Exp Neurol. 2014 Apr;73(4):295-304. doi: 10.1097/NEN.0000000000000052.

6.

Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons.

Riudavets MA, Iacono D, Resnick SM, O'Brien R, Zonderman AB, Martin LJ, Rudow G, Pletnikova O, Troncoso JC.

Neurobiol Aging. 2007 Oct;28(10):1484-92. Epub 2007 Jun 28.

7.

Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology.

Ikonomovic MD, Mufson EJ, Wuu J, Cochran EJ, Bennett DA, DeKosky ST.

J Alzheimers Dis. 2003 Feb;5(1):39-48.

PMID:
12590165
8.

Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment.

Nelson PT, Abner EL, Scheff SW, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Patel E, Markesbery WR.

Neurosci Lett. 2009 Feb 6;450(3):336-9. doi: 10.1016/j.neulet.2008.11.006. Epub 2008 Nov 8.

9.

Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.

Sabbagh MN, Shah F, Reid RT, Sue L, Connor DJ, Peterson LK, Beach TG.

Arch Neurol. 2006 Dec;63(12):1771-6.

PMID:
17172618
10.

Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD.

Sabbagh MN, Cooper K, DeLange J, Stoehr JD, Thind K, Lahti T, Reisberg B, Sue L, Vedders L, Fleming SR, Beach TG.

Curr Alzheimer Res. 2010 Jun;7(4):280-6.

11.

Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study.

Riley KP, Snowdon DA, Desrosiers MF, Markesbery WR.

Neurobiol Aging. 2005 Mar;26(3):341-7.

PMID:
15639312
12.

Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.

Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM.

Arch Neurol. 2006 May;63(5):693-9. Erratum in: Arch Neurol. 2007 Sep;64(9):1360-1.

PMID:
16682538
13.

Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease.

Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC.

Arch Neurol. 2001 Sep;58(9):1395-402.

PMID:
11559310
14.

Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease.

Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S, Saragovi HU, Kordower JH.

J Comp Neurol. 2000 Nov 6;427(1):19-30.

PMID:
11042589
15.

Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.

Tam CW, Burton EJ, McKeith IG, Burn DJ, O'Brien JT.

Neurology. 2005 Mar 8;64(5):861-5.

PMID:
15753423
16.

Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease.

Mueller SG, Schuff N, Yaffe K, Madison C, Miller B, Weiner MW.

Hum Brain Mapp. 2010 Sep;31(9):1339-47. doi: 10.1002/hbm.20934.

17.

Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.

Jauhiainen AM, Pihlajamäki M, Tervo S, Niskanen E, Tanila H, Hänninen T, Vanninen RL, Soininen H.

Hippocampus. 2009 Feb;19(2):166-75. doi: 10.1002/hipo.20494.

PMID:
18777563
18.

Hippocampus and entorhinal cortex in mild cognitive impairment and early AD.

Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hänninen T, Laakso MP, Hallikainen M, Vanhanen M, Nissinen A, Helkala EL, Vainio P, Vanninen R, Partanen K, Soininen H.

Neurobiol Aging. 2004 Mar;25(3):303-10.

PMID:
15123335
19.

Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.

Guillozet AL, Weintraub S, Mash DC, Mesulam MM.

Arch Neurol. 2003 May;60(5):729-36.

PMID:
12756137
20.

Activation of caspase-6 in aging and mild cognitive impairment.

Albrecht S, Bourdeau M, Bennett D, Mufson EJ, Bhattacharjee M, LeBlanc AC.

Am J Pathol. 2007 Apr;170(4):1200-9.

Supplemental Content

Support Center